Beta 2 Microglobulin (B2M) is a protein found in the blood and urine of humans and other primates. It is used as a marker for diagnosing a variety of diseases, including kidney disease, multiple myeloma, and lymphoma. B2M is also used to monitor the progression of these diseases and to assess the effectiveness of treatments. In the diagnostics market, B2M is used to detect and monitor a variety of diseases. It is used to measure the amount of B2M in the blood and urine, which can indicate the presence of certain diseases. B2M is also used to monitor the progression of these diseases and to assess the effectiveness of treatments. The B2M diagnostics market is highly competitive, with a number of companies offering products and services. Some of the major players in the market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, and Thermo Fisher Scientific. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
